This Solicitation opportunity from Department Of Defense was posted on May 17, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
HYDROCHLOROTHIAZIDE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract entails the procurement of Hydrochlorothiazide Tablets, USP, specifically 25 mg strength in bottles containing 100 tablets each. The total quantity ordered is three bottles, with delivery required within 20 days to a specified destination. This transaction is governed by detailed technical and quality requirements outlined in the Defense Logistics Agency's (DLA) Master List available online, along with adherence to FDA regulations. Packaging must conform to DLA's packaging requirements, including Medical Marking Standard No. 1, ensuring products are properly sealed and protected during shipment, with shelf life set at 24 months non-extendable. The tablets are intended for oral administration and the contract includes instructions for labeling, storage at controlled room temperature, and handling of any hazardous material in compliance with federal standards. The contract is issued by the Department of Defense’s Medical Supply Chain Pharmacy FSA and facilitated under solicitation number SPE2DP-26-T-3420. It involves specific manufacturers and suppliers identified by National Drug Codes (NDC) and references the required unit of issue and inspection points as destination acceptance. Transportation and delivery will be executed according to set procedures and contract stipulations, with the final delivery address listed as the USNS Alan Shepard in the FPO AP 96678 area. Buyers and contractors are instructed to communicate with designated points of contact for confirmation and compliance with all regulatory and contractual requirements.
General Info
Agency
NAICS
Place of Performance
UNIT 100494 BOX 1, FPO, AP, 96678, USSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
HYDROCHLOROTHIAZIDE TABLETS, USP,.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RX ONLY, FOR ORAL ADMINISTRATION. EACH TABLET CONTAINS 25 MILLIGRAMS
(MG) OF HYDROCHLOROTHIAZIDE, USP AS THE ACTIVE INGREDIENT.. UNIT OF
ISSUE IS A BOTTLE CONTAINING 100 TABLETS. .. STORE AT 20° TO 25°C (68°
TO 77°F) [SEE USP CONTROLLED ROOM TEMPERATURE]. LABELING AND MARKING
MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY
2013. 1/9/2017.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-3420
SECTION B
.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00172-2083-60 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC51407-0331-01 GLENDALE MISSIONARY BAPTIST CHURCH 7EP57 P/N NDC69315-0131-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016779888 0001 BT 3.000
NSN/MATERIAL:6505015544306
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N23193
USNS ALAN SHEPARD T AKE 3
UNIT 100494 BOX 1
FPO AP 96678
US
SPE2DP-26-T-3420
SECTION B
PR: 7016779888 PRLI: 0001 CONT’D
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
N23193
USNS ALAN SHEPARD T AKE 3
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N231936133S294
RDD: 777
PROJ: HJ5 TP 2
SUPP ADD: YPHARM SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:05/18/2026
SPE2DP-26-T-3420 NSN/Part Number: 6505-01-554-4306 Quantity: 3 BT Purchase Request: 7016779888QTY: 3 Delivery: 20 days ADO
